Cover Image
Market Research Report

Chiral Technology

Published by Global Industry Analysts, Inc. Product code 236736
Published Content info 218 Pages
Delivery time: 1-2 business days
Price
Back to Top
Chiral Technology
Published: February 1, 2018 Content info: 218 Pages
Description

This report analyzes the worldwide markets for Chiral Technology in US$ Thousand by the following Products, and End Use markets: Products - Intermediates, Analytical, and Others; End Use markets - Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as -

Agilent Technologies, Inc.
Albemarle Corporation
BASF SE
Cambrex Corporation
Chiral Quest (Suzhou) Co., Ltd.
Daicel Corporation.

Table of Contents
Product Code: MCP-1098

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitation

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Chiral Technology Enabling Products
    • Chiral Intermediates
    • Analytical Products
    • Other Products
  • Chiral Technology End-Use Markets
    • Pharmaceuticals
    • Agrochemicals

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Chiral Technology: An Introductory Prelude
  • Good Tidings for Chiral Technology
  • Global Market Outlook
  • Developed Markets: Traditional Revenue Contributors
  • Developing Countries Turbo Charge Future Market Growth
    • Table 1: Global Chiral Technology Market - Geographic Regions Ranked by CAGR (Value) for 2015-2022: Rest of World, US, Japan, and Europe (includes corresponding Graph/Chart)
  • Chiral Intermediates Garner a Larger Pie
    • Table 2: World Chiral Technology Enabling Products Market by Segment (2017E): Percentage Breakdown by Value Sales for Chiral Intermediates, Chiral Analytical Products, and Others (includes corresponding Graph/Chart)
  • Pharmaceuticals: The Largest End-Use Application Domain
  • Stable Economic Scenario Lends Momentum for Market Growth
    • Table 3: World Real GDP Growth Rates in % (2016-2018P): Breakdown by Country/Region (includes corresponding Graph/Chart)
  • Competitive Scenario
  • American Enterprises Dominate the Market
  • European Entities Vie to Extend their Share
  • Asian Players Seek Global Audience
  • M&A Activity
    • Select M&A Deals Involving Chiral Technology Vendors Finalized in the Recent Past

2. MARKET TRENDS, DRIVERS & ISSUES

  • Chiral Technology Plays Pivotal Role in the Pharmaceutical Industry
  • Demand for Chiral-based Therapeutic Drugs Augments Growth
    • New Legislations Push Chiral Technology Demand
  • Single Enantiomer Drugs Gain Prominence
  • Increasing Reliance on Generic Approaches
  • Organizations Extend Approaches
  • Pharma Companies' Association with Universities
  • Uptrend in Healthcare Expenditure Underpins Present & Future Growth
    • Table 4: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
    • Table 5: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)
  • Chiral Separation Registers Impressive Growth
  • Soaring Demand for Chiral Separation Columns
  • Chiral Chromatography Continues to Gain Momentum
    • SFC Holds Tremendous Potential
    • Emerging Regions to Drive Demand for Chiral Chromatography Columns
  • Advancements and Challenges Related to Chiral Separation
  • Chiral Analysis Evoles into a Critical Step for Pharmaceutical Industry
  • Biocatalysis Witnesses Increasing Significance in Development through Production of Novel Compounds
  • Increasing Significance of Biocatalysis
  • Predominant Use of Polysaccharides Derivatives as CSPs
  • Automation: Introduction of Instruments Supporting Chiral Processes, a Growing Trend
  • Access to Extensive Range of Enzymes Drive Biocatalyst Use for API Synthesis
  • Sustainable Chiral Chemistry
  • Progress in Molecular Engineering
  • Availability to Wide Range of Enzymes
  • Focus on Synthetic Biology
  • Chemo-Catalysis to Retain Significance
  • Cascade Organocatalysis
  • Issues & Challenges
  • Key Concerns Hindering Growth of Chiral Technology
  • Limitations of Chiral Separation Methods

3. TECHNOLOGICAL ADVANCEMENTS

  • Researchers Explore Methods to Achieve Large-Scale Synthesis of Single-Structure SWCNTs
  • CHAIN Biotechnology Concludes Ambitious Research Project
  • Researchers Add Chiral Organocatalyst to Activate C-C Single Bond
  • Researchers Focus on New Technique for Chiral Separation
  • Chiral Phosphines to Aid Synthesis of Asymmetric Reactions
  • Role of Molecular Propeller Effect in Chiral Separation/Analysis
  • Researchers Develop HPLC Technique for Direct Enantioseparation of B-Blockers

4. CHIRAL TECHNOLOGY - AN OVERVIEW

  • An Insight into Chiral Technology
  • Techniques Used for Achieving Single-Isomers
  • Importance and Advancements
  • Chiral Technology - A Historical Perspective
  • Definitions
  • Chiral Technology Enabling Products
  • Chiral Intermediates
  • Analytical Products
  • Other Products
  • Chiral Technology End-Use Markets
  • Pharmaceuticals
  • Agrochemicals
  • Functioning of Chiral Molecules
  • Chiral Preparation Process
  • Traditional Methods
  • Processes
  • Market Drivers
  • Inhibitor
  • Biological Methods
  • Processes
  • Market Drivers
  • Inhibitor
  • Asymmetric Methods
  • Processes
  • Market Drivers
  • Inhibitor
  • Chiral Separation
  • Factors Influencing the Efficacy of Chiral Separation
  • Recent Approaches in Chiral Separation
  • Alternatives to Standard Methods
  • Chromatography - The Widely Used Method for Separation
    • How it Works?
      • Chiral Mobile Phase Additive (CMPA)
      • Chiral Stationary Phase (CSP)
      • List of Select Generic Versions of Derivatized Amylose and Cellulose Phases
      • Types of CSPs
      • Macrocyclic Glycoprotein CSPs
      • Cyclodextrin CSPs
      • Cyclofructan CSPs
      • Challenges and Novel Concepts in the Development of Chiral Stationary Phases
      • Novel Concepts
      • Bonded and Derivatized 6-carbon or 7-carbon Cyclofructan
      • Derivatized Spiral Chiral Polymer
      • Development in Biomedical Analysis
      • Chiral Recognition
      • Protein Chiral Stationary Phases
      • Carbohydrate Columns
      • Pirkle Columns
  • Crystallization
  • Solvent Extraction
  • Kinetic Resolution
  • Capillary Electrophoresis
  • Receptor Based Resolution
  • Miscellaneous Separative Techniques
  • Chiral Synthesis

5. CHIRAL TECHNOLOGY - DEVELOPMENT VIS-A-VIS ACQUISITION

  • In-House Creation & Development
  • Acquisition of Technology
  • "Economics" of Chiral Technology

6. CHIRAL ANALYSIS

  • Chiral Analysis: A Primer
  • Chiral Analysis Products
  • Chiral Analytical Chromatography
  • Chiral Liquid Chromatography
  • Supercritical Fluid Chromatography - Substitute to LC for Enantiomer Separations
  • Chiral Gas Chromatography
  • Chiral Simulated Moving Bed Chromatography
  • Partition Chromatography
  • Adsorption Chromatography
  • Computer Assisted Resolution
  • Chiral Polarimetry
  • Other Chiral Analytical Techniques
  • Calorimetry
    • Differential Scanning Calorimetry (DSC)
  • Enzymatic Assay
  • Immunoassay
  • Isotope Dilution
  • Nuclear Magnetic Resonance (NMR)
  • X-Ray Crystallography

7. APPLICATION MARKETS

  • Pharmaceuticals - The Largest Market
  • Changing Face of the Pharmaceutical Industry: A Review
  • Analysis of Chiral Drugs
    • Select Companies Involved in Chiral Technology Market
    • Select Single-Enantiomer Drugs Worldwide
  • Drugs Built on Chiral Technology
    • Analgesics
    • Anesthetics
    • Anti-Infective Products
    • Cardiovascular System (CVS) Products
    • Angiotensin-Converting Enzyme (ACE) Inhibitors
    • Beta-Blockers
    • Calcium Channel Blockers
    • Diuretics
    • Vasodilators
    • Central Nervous System (CNS) Agents
    • Anticonvulsants
    • Sedatives and Tranquilizers
    • Stimulants and Antidepressants
    • Oncogenic (Cancer-Treatment) Products
  • Biochemicals
  • Oligonucleotides
  • Oxyacids
  • Amino Acids
    • Alanine Racemase Chiral Analogue: A Breakthrough Chiral Converting Agent
    • Commercial Development
    • Scope
  • Sugars and Other Oligosaccharides
  • Vitamins
  • Peptides
  • Agrochemicals - A Thriving Market
  • Herbicides
  • Insecticides
  • Fungicides
  • Other Products
  • Liquid Crystals
  • Flavor and Aroma Chemicals

8. CHIRAL ISOMERISM

  • Organic Chemical Isomerism Types
  • Structural Isomerism
    • Chain Isomerism
    • Position Isomerism
    • Functional Group Isomerism
  • Stereoisomerism
  • Dynamic Isomerism (Tautomerism)
  • Patents

9. REGULATORY & ENVIRONMENTAL ISSUES - A REVIEW

10. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Phenomenex Releases Zebron(tm) GC Columns
  • Phenomenex Unveils Immobilized Lux Chiral LC-SFC Selector
  • Solvias Rolls Out Chiral Brønsted Acid Catalysts
  • Chiral Technologies Unveils Sub-2 µm Immobilized CSP
  • Phenomenex Unveils Lux i-Cellulose-5 Chiral Columns
  • Chiral Technologies Launches CHIRALPAK(r) IG
  • Phenomenex Introduces Amylose-1 Chiral Stationary Phase
  • Regis Technologies Extends Chiral Column Product Line

11. RECENT INDUSTRY ACTIVITY

  • Cambrex to Expand Charles City Plant
  • Sterling Pharma Collaborates with Newcastle University
  • Phenomenex Inaugurates New Facility in Sacramento
  • Sterling Pharma Commences Operations as Independent CDMO
  • Sterling Pharma to Expand its Dudley Site
  • Phenomenex Commences Direct Operations in Switzerland
  • Chiral Technologies Appoints Biotecnology Latina as Exclusive Distributor
  • Agilent Technologies Inaugurates New Technology Center in Folsom, California
  • Cambrex to Acquire PharmaCore
  • Danaher Acquires Phenomenex
  • Chiral Technologies Inks Distributor Agreement with Scanco International
  • Chiral Technologies and GreenCentre Canada Inks Agreement
  • Chiral Technologies Partners with Strem Chemicals
  • Jingbo Agrochemical Opens High Chiral Ratio Indoxacarb Technical Manufacturing Plant
  • Johnson Matthey Divests Alfa Aesar to Thermo Fisher
  • Johnson Matthey Takes Over Pharmorphix
  • Merck Snaps Up Sigma-Aldrich

12. FOCUS ON SELECT PLAYERS

  • Agilent Technologies, Inc. (USA)
  • Albemarle Corporation (USA)
  • BASF SE (Germany)
  • Cambrex Corporation (USA)
  • Chiral Quest (Suzhou) Co., Ltd. (China)
  • Daicel Corporation (Japan)
  • Chiral Technologies, Inc. (USA)
  • Johnson Matthey Fine Chemicals (UK)
  • Phenomenex, Inc. (USA)
  • Regis Technologies, Inc. (USA)
  • Shimadzu Corporation (Japan)
  • Sigma Aldrich Corp. (USA)
  • Solvias AG (Switzerland)
  • Sterling Pharma Solutions Ltd. (UK)
  • Thermo Fisher Scientific, Inc. (USA)
  • YMC America, Inc. (USA)

13. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for Chiral Intermediates by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 12: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for Chiral Analytical Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The Prime Market
    • Chiral Technology Assumes Critical Importance in Pharmaceuticals Manufacturing
    • Agrochemicals Continue to Extend Opportunities
      • Pivotal Role of Agrochemicals in Modern Farming Bodes Well for Market Growth
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 24: The US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 25: The US Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 26: The US 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 27: The US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 28: The US Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 29: The US 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

2. JAPAN

  • A. Market Analysis
    • Select Key Players
  • B. Market Analytics
    • Table 30: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 31: Japanese Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 32: Japanese 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 33: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 34: Japanese Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 35: Japanese 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Largest Consumer of Chiral Compounds
    • Product Launch
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 36: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 37: European Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 38: European 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 39: European Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: European Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 41: European 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4. REST OF WORLD

  • A. Market Analysis
    • China - A Hub for Pharmaceutical Manufacturing
    • Strategic Corporate Developments
    • Select Key Player
  • B. Market Analytics
    • Table 42: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: Rest of World Historic Review for Chiral Technology Enabling Products by Segment - Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 44: Rest of World 14-Year Perspective for Chiral Technology Enabling Products by Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 45: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 46: Rest of World Historic Review for Chiral Technology by End-Use Application - Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 47: Rest of World 14-Year Perspective for Chiral Technology by End-Use Application - Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Back to Top